Home
Markets
Charts & Ideas
Algo
News
Store
Brokers
Download
Economic Calendar
Trading Signals
WebTerminal
Type
/
to search: @user, $symbol
Search
Log in
Create an account
English
Русский
中文
Español
Português
日本語
Deutsch
한국어
Français
Italiano
Türkçe
VSTM
#2683
Verastem, Inc.
5.7
2
+1.42%
Sector:
Base:
Profit Currency:
Daily Range
Year Range
Daily Change
+1.42%
Monthly Change
-11.86%
6 month change
-38.49%
Year Change
+6.32%
Previous Close
5.6
4
Open
5.7
2
Bid
Ask
Low
5.7
2
High
5.7
2
Volume
58
Markets
US Stock Market
Healthcare
VSTM
Open full chart
Financials
Overview
Statement
Statistics
Dividends
Quarterly
Annual
Value
2020
2021
2022
2023
2024
TTM
Dividends per share
—
—
—
—
—
—
Dividend yield %
—
—
—
—
—
—
Payout ratio %
—
—
—
—
—
—
Verastem Inc
Verastem, Inc., doing business as Verastem Oncology, is an American pharmaceutical company that develops medicines to treat certain cancers. Headquartered and founded in Boston, Massachusetts, the firm is a member of NASDAQ Biotechnology Index.
News
What Makes Verastem (VSTM) a New Buy Stock
Verastem Stock Rises Nearly 8% on Strong Q4 & 2025 Preliminary Results
B.Riley reiterates Buy rating on Verastem stock, maintains $16 target
Verastem reports $17.5 million in Q4 revenue for cancer treatment
Verastem stock rating initiated at Buy by H.C. Wainwright with $18 target
Immuneering: Strong Buy Despite Decline In Share Price On Atebimetinib Data (NASDAQ:IMRX)
Revolution Medicines stock surges over 20% on potential AbbVie acquisition
What's Going On With Verastem Stock Friday? - Verastem (NASDAQ:VSTM)
Verastem stock steady as Mizuho reiterates Outperform rating
Verastem: Downgrading To Buy Based On RAMP-203 Setback In Targeting KRAS G12C NSCLC (VSTM)
Verastem stock falls after discontinuing KRAS G12C lung cancer trial
Verastem discontinues KRAS G12C lung cancer trial to focus on G12D